| Literature DB >> 20814500 |
R Shiva Kumar1, Abraham Kuruvilla.
Abstract
Congenital myasthenic syndromes (CMSs) are a heterogeneous group of disorders, characterized by dysfunction of neuromuscular junction (NMJ) transmission. These syndromes are genetically inherited and are present since birth. Some have characteristic clinical or electrodiagnostic features but in many cases determination of the specific form requires genetic studies or specialized morphological and electrophysiological studies on muscle tissue. We report a case of a 4-year-old boy with progressive ptosis and limitation of ocular movements who was diagnosed as slow-channel CMS based on the characteristic electrodiagnostic features. Repetitive compound muscle action potentials (R-CMAPs) were recorded after single nerve stimulus, with decremental response after repetitive trains performed at 3 Hz. CMSs are at times clinically difficult to distinguish from acquired myasthenia. The characteristic clinical and electrodiagnostic features help in the diagnosis and enable rational therapy. In this article we discuss the characteristics of synaptic R-CMAPs.Entities:
Keywords: Congenital myasthenic syndromes; repetitive CMAPs; slow-channel syndrome
Year: 2010 PMID: 20814500 PMCID: PMC2924514 DOI: 10.4103/0972-2327.64645
Source DB: PubMed Journal: Ann Indian Acad Neurol ISSN: 0972-2327 Impact factor: 1.383
Figure 1(a) Decremental response of 15% from the facial muscles. (b) Double CMAP was recorded after single stimulus from nasalis with the first CMAP larger than the second. (c) Shows appearance of post-exercise decremental response at 3 Hz in the second CMAP before the first CMAP
Characteristics of R-CMAPs[3]
| Synaptic R-CMAP | Neural R-CMAP | |
|---|---|---|
| Origin | Abnormal synaptic event reactivates one muscle fiber, and can re-excite the nerve fiber, in turn exciting all muscle fibers of the same motor unit | Abnormal motor axon generates impulse trains, spontaneously or in the wake of a passing impulse; these activate the motor unit |
| Associated disorders | AChE blocking: | Neuromyotoni |
| Drugs in MG | Familial paroxysmal kinesigenic ataxia and continuous myokymia | |
| Organophosphate poisons | ||
| CM with AChE deficiency | ||
| Slow-channel syndrome | ||
| Number of extra discharges | One; rarely two | Up to 25 |
MG: myasthenia gravis; ACh: acetylcholine; AChE: acetylcholinesterase, CM: congenital myasthenia